A new study published in Molecular Biomedicine uncovers how post-translational modifications (PTMs) of fibrinogen—a key blood plasma protein—affect clot formation, structure, and degradation. The research provides critical insights into thrombosis-related disorders, highlighting potential therapeutic targets for cardiovascular and inflammatory diseases.

A recent study published in Molecular Biomedicine has revealed the promising therapeutic potential of tumor-infiltrating lymphocytes (TILs) derived from metastatic lymph nodes in treating advanced cervical cancer. Conducted by researchers from the Biotherapy Center and Cancer Center of the First Affiliated Hospital of Zhengzhou University and Grit Biotechnology in Shanghai, the study provides crucial insights into personalized immunotherapy for patients with refractory solid cancers.